Corporate Health Tie-Ups: The B2B Revenue Line Most Hospitals Still Treat as a Side Hustle

Every hospital in Tamil Nadu with more than 100 beds has a “Corporate Services” page somewhere on its website. Open it. It is almost always a single paragraph, a phone number, and a form nobody checks. Compare that to the page the same hospital built for, say, cardiac surgery — professionally photographed, keyword-optimized, updated quarterly. The gap between those two pages is the gap between how hospitals treat patient acquisition and how they treat B2B revenue. One gets a marketing budget. The other gets a relationship manager’s personal phone number and a handshake.

That gap is costing hospitals a channel that is growing, recurring, and increasingly being captured by companies that were never hospitals to begin with.

Corporate health tie-ups — annual checkup contracts for employees, on-site or facility-based wellness screening, OPD empanelment for walk-in employee care, sometimes extended to family members — are not a niche. They are a real B2B line item that HR and finance teams budget for every year, renew every year, and increasingly shop around for every year. The hospitals losing this business aren’t losing it to a better hospital down the road. They’re losing it to platforms that treat corporate health as a packaged product with a price list, an account manager, and a renewal process — while the hospital is still treating it as something the business development guy handles over WhatsApp.

What Companies Are Actually Buying

Strip away the jargon and corporate health spend breaks into a handful of concrete line items, confirmed by how the platforms selling into this space package their own offerings:

• Annual health checkup packages for employees: This is the anchor product. Packages typically scale by age and risk — a baseline panel (vitals, lipid profile, kidney and liver function, complete blood count, thyroid/TSH, vision and hearing, ECG for employees over 35) for a younger workforce, and more comprehensive cardiac and chronic-disease screening for an older one. Pazcare, the Bangalore-based insurtech and benefits platform that brokers these screenings for HR teams, prices basic panels at roughly ₹800–1,500 per employee and comprehensive 80–100 parameter packages at ₹2,500–6,000 per employee — a range worth knowing before you quote a corporate client.
• On-site or facility-based screening: Large single-location employers often prefer a diagnostic team coming to the office rather than sending hundreds of employees to a facility across appointment slots. The providers active in this exact space — Redcliffe Labs, Dr Lal PathLabs, Apollo Diagnostics, Max Lab, Metropolis Healthcare — report standard turnaround of 24–48 hours on digital reports, with Redcliffe explicitly marketing same-day results. That window is now the market benchmark, not a differentiator you get credit for mentioning vaguely.
• OPD empanelment for employee walk-ins: Beyond the annual screening, companies empanel hospitals so employees can walk in for routine consultations, often under a group health policy’s OPD rider, with the hospital billing the insurer or a third-party administrator rather than the employee paying out of pocket.
• Family coverage extensions: Larger or more mature corporate accounts extend some of the above to spouses and dependents, usually as a retention lever the HR team negotiates in year two or three of a contract, not at initial signing.

None of this is exotic. It is the same clinical capacity a hospital already has — labs, physicians, cardiology, radiology — sold on a different commercial structure: contracted, recurring, invoiced to a company instead of a patient.

Who the Buyer Actually Is — And Why That Changes Everything

A hospital’s patient-facing marketing is built around someone searching in pain, in fear, or in confusion, and converting within days. The corporate buyer is a completely different animal. It is usually an HR or People Operations team evaluating vendors months before a policy renewal date, running the decision past finance, and — increasingly — not even talking to the hospital directly.

That last point matters more than most hospital leadership teams realize. A growing share of this spend now routes through intermediary platforms. Pazcare sits between HR teams and screening providers, coordinating scheduling, communications, report delivery, and follow-up, and plugging screening into a broader benefits design. Tata 1mg runs a dedicated corporate wellness vertical with its own enquiry funnel for annual checkups, vaccination camps, mental health counseling, and on-site dental and eye camps. And in December 2025, Tata 1mg announced a partnership with OneBanc — the workplace banking and benefits platform — to embed its diagnostics, medicine delivery, and preventive wellness network directly into payroll infrastructure, in a deal framing the addressable opportunity at over ₹12,000 crore annually across diagnostics, OPD care, and preventive wellness.

Apollo Hospitals made a comparable move in August 2025, partnering with OneBanc to offer employers preventive health checkups across Apollo’s network, virtual specialist consultations, and structured programs for stress and lifestyle-disease management, tied to OneBanc’s claims analytics so HR and finance leaders can actually measure program impact rather than buy it on faith. Apollo’s Executive Vice Chairperson Preetha Reddy framed the shift explicitly: healthcare needs to move “beyond episodic interventions to become continuous, personalised, and preventive.”

The pattern across both deals is the same, and it is the single most important fact in this entire channel: the HR buyer increasingly wants to talk to one platform, not negotiate separately with five hospitals and three diagnostic chains. A hospital that has no clear B2B product, no published package structure, and no account management process is simply invisible to a buyer who is comparing dashboards and data feeds, not comparing waiting rooms.

What Actually Makes a Hospital’s B2B Offer Competitive

It is not price. Every operator in this space has converged on roughly the same price bands, because the underlying lab costs are similar across providers. What separates the offers that win renewal from the ones that get replaced is operational, not clinical:

• Report turnaround: 24–48 hours is now the expectation, not a selling point. A hospital promising a week is already out of the conversation.
• Digital-first report delivery: with abnormal values flagged automatically rather than buried in a PDF an employee has to interpret alone.
• Scheduling that works for an HR team managing hundreds of people: not one that assumes each employee will individually call and book — batch scheduling, grade- or age-band customization, and clear communication templates HR can forward without rewriting.
• A named account manager: not a rotating front-desk contact, who owns the relationship through the full annual cycle: onboarding, mid-year utilization reporting, and renewal.
• Follow-up pathways, not just test results: Pazcare’s own guidance to HR buyers is explicit on this: a checkup without a referral or counseling pathway for abnormal findings is a wasted spend, and companies increasingly judge vendors on whether they close that loop.

Why the Handshake-Deal Model Is Losing

Most hospitals that do win corporate accounts win them the same way: a BD executive’s personal network, a discounted health-checkup camp pitched once a year, and a contract that gets renewed mostly out of inertia rather than demonstrated value. There is no positioning document, no pricing tiers, no case for why this hospital specifically should hold the account next year.

That model survives exactly until a platform or a hospital-group competitor shows up with a packaged product, a named point of contact, and a dashboard the HR team can show its own CFO. At that point the incumbent hospital isn’t losing on clinical quality — it’s losing because it never built anything the buyer could compare against. This is precisely the opening that Pazcare, Tata 1mg, and OneBanc-style partnerships are exploiting at scale: not better medicine, but a better-marketed, better-administered product wrapped around the same medicine.

A Practical Framework for Marketing This Channel

1. Build a dedicated corporate health page — not a paragraph on a generic page: It needs its own URL, written for an HR buyer: named packages with what’s included at each tier, turnaround commitments, how on-site logistics work, and a clear enquiry path that routes to a person, not a general inbox.
2. Publish pricing logic, even if not exact numbers: HR teams comparing three vendors will not chase a hospital that makes them call for a quote when two competitors already show tiered packages online.
3. Name an account owner for every corporate contract: and make that visible in the sales process — it is the single cheapest trust signal in this entire category.
4. Treat it as a renewal business from day one: Build the mid-year check-in and the pre-renewal utilization summary into the contract terms before signing, not as an afterthought six weeks before the contract lapses. This is where most hospitals lose accounts quietly — not through a bad screening experience, but through twelve months of silence before a competitor’s renewed pitch lands first.
5. Track and report utilization data back to the HR buyer: the same way OneBanc’s claims-analytics layer does for Apollo and Tata 1mg. A hospital that can hand an HR director a one-page summary of screening uptake, flagged findings, and follow-up completion rates is offering something most local competitors still cannot.

Corporate health tie-ups will keep growing as a share of hospital revenue, and the hospitals that market this channel as deliberately as they market cardiac care or IVF will keep the accounts the handshake-deal hospitals lose. The clinical capacity is already sitting there. What’s missing is the page, the pricing, and the account manager that make it legible to the person signing the contract.

Sources

• Apollo Hospitals and OneBanc Forge Strategic Partnership to Redefine Corporate Wellness
• Tata 1mg x OneBanc Partner to Plug India’s Rs 30,000 Crore White-Collar Health Drag
• Pazcare: Top Companies Offering On-Site Corporate Health Screenings for Employees in India
• Pazcare: Why Corporate Health Checkup Packages Are Important for Workplaces
• Tata 1mg: Employee Wellness Plans
• Tata 1mg: Corporate Wellness Partnerships